Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Experimental study on repairing skin defect by tissue-engineered skin substitute compositely constructed by adipose-derived stem cells and fibrin gel.

Zeng RX., He JY., Zhang YL., Liu XX., Zhang Y., Tang Q.

Animal Study on Chronic Wound, published in Eur Rev Med Pharmacol Sci (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Eur Rev Med Pharmacol Sci (2017)
Country
Italy
Reported sample size
—
Source database
PubMed
PMID
28745800
Citations
5

Abstract (original English)

To study the application value of artificial skin substitute compositely constructed by adipose-derived stem cells and fibrin gel in skin defect. Adipose-derived stem cells (ADSCs) were obtained from healthy pure green fluorescent protein (GFP) transgenic mice and were proved to have multiple differentiation potentials. They compositely constructed artificial skin substitute in vitro with fibrin gel. 24 SD rats of either gender, with the gestational age of 3-5 weeks, were divided into four groups in the experiment, namely model group (autologous skin flap transplantation), adipose-derived stem cell transplantation group, fibrin gel transplantation group and compound transplantation group, 6 rats for each group. At the skin blood flow (measured by applying laser Doppler rheometer) and survival rate of the flap on 7d and 21d respectively, the materials were transplanted at back skin injury (1 cm×1 cm) to prepare tissue slice for routine HE staining. The conditions of wound healing were observed, and the angiogenesis of flap neovascularization was detected by the immunofluorescent assay. The skin blood flow, the survival rate of flap and density of neovascularization 7d and 21d after transplantation were significantly higher than those of stem cell group, followed by the model group, with the lowest ones in the fibrin gel group. The differences had statistical significance (p<0.05

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsCells, CulturedFibrin Tissue AdhesiveMaleMiceRatsRats, Sprague-DawleySkinSkin, Artificial

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research